In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA)

References

• WorkmanPHow much gets there and what does it do?: the need for better pharmacokinetic and pharmacodynamic endpoints in contemporary drug discovery and developmentCurr Pharm Des2003911 891 90212678873
   PubMed Web of Science ®Google Scholar
• DiMasiJAHansenRWGrabowskiHGThe price of innovation: new estimates of drug development costsJ Health Econ2003222 151 18512606142
   PubMed Web of Science ®Google Scholar
• SongCMLimSJTongJCRecent advances in computer-aided drug designBrief Bioinform2009105 579 59119433475
   PubMed Web of Science ®Google Scholar
• KlebeGVirtual ligand screening: strategies, perspectives and limitationsDrug Discov Today20061113–14 580 59416793526
   PubMed Web of Science ®Google Scholar
• HouTXuXRecent development and application of virtual screening in drug discovery: an overviewCurr Pharm Des2004109 1011 103315078130
   PubMed Web of Science ®Google Scholar
• KapetanovicIMComputer-aided drug discovery and development (CADDD): in silico-chemico-biological approachChem Biol Interact20081712 165 17617229415
   PubMed Web of Science ®Google Scholar
• WHO [webpage on the Internet]Global tuberculosis report 2015GenevaWHO2015 Available from: http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1Accessed November 6, 2015
   Google Scholar
• BillonesJBCarrilloMCOOrganoVGToward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosis l,d-transpeptidase 2Drug Des Dev Ther201610 1147 1157
   PubMed Web of Science ®Google Scholar
• BillonesJBCarrilloMCOrganoVMacalinoSJYEmnacenISyJBVirtual screening against Mtuberculosis 7,8-diaminopelargonic acid synthase (MtbBioA) and in silico toxicity evaluation of top hitsCurr Enzym Inhib2014102 105 112
   Google Scholar
• BillonesJBCarrilloMCOOrganoVGMacalinoSJYEmnacenIASyJBAVirtual screening against Mycobacterium tuberculosis lipoate protein ligase B (MtbLipB) and in silico ADMET evaluation of top hitsOrient J Chem2013294 1457 1468
   Google Scholar
• UyVCCBillonesJBTowards antituberculosis drugs: virtual screening for potential inhibitors of pantothenate synthetase of Mycobacterium tuberculosisPhil Sci Lett201252 122 130
   Google Scholar
• YangCTMBillonesJBTowards antituberculosis drugs: molecular docking of curcumin and its analogues to pantothenate synthetasePhil J Sci20121412 187 196
   Google Scholar
• BillonesJBValleAMFStructure-based design of inhibitors against maltosyltransferase GlgEOrient J Chem2014303 1137 1145
   Google Scholar
• ClavioNABBillonesJBVirtual screening against Mycobacterium tuberculosis isocitrate lyase and in silico ADME-Tox evaluation of top hitsJ Chem Pharm Res2014610 727 738
   Google Scholar
• CordovaDLMAbuelRJDGalinganaMOVillanuevaLABillonesJBPiggyback drug development: molecular docking of Entacapone analogues as direct M. tuberculosis InhA inhibitorsJ Chem Pharm Res201575 636 642
   Google Scholar
• SampacoABIIIBillonesJBVirtual screening of natural products, molecular docking and dynamics simulations on M. tuberculosis S-adenosyl-L-homocysteine hydrolaseOrient J Chem2015314 1859 1865
   Google Scholar
• BillonesJBReverse docking study unravels the potential Mycobacterium tuberculosis enzyme targets of Agelasine FOrient J Chem2016322 851 858
   Google Scholar
• BhorVMDevSVasanthakumarGRSuroliaASpectral and kinetic characterization of 7,8-diaminopelargonic acid synthase from Mycobacterium tuberculosisIUBMB Life2006584 225 23316754301
   PubMed Web of Science ®Google Scholar
• KäckHSandmarkJGibsonKSchneiderGLindqvistYCrystal structure of diaminopelargonic acid synthase: evolutionary relationships between pyridoxal-5′-phosphate-dependent enzymesJ Mol Biol19992914 857 87610452893
   PubMed Web of Science ®Google Scholar
• DeySLaneJMLeeRERubinEJSacchettiniJCStructural characterization of the Mycobacterium tuberculosis biotin biosynthesis enzymes 7,8-diaminopelargonic acid synthase and dethiobiotin synthetaseBiochemistry20104931 6746 676020565114
   PubMed Web of Science ®Google Scholar
• Woong ParkSKlotzscheMWilsonDJEvaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expressionPLoS Pathog201179 e100226421980288
   PubMed Web of Science ®Google Scholar
• MannSPlouxO7,8-Diaminoperlargonic acid aminotransferase from Mycobacterium tuberculosis, a potential therapeutic target: characterization and inhibition studiesFEBS J200627320 4778 478916984394
   PubMed Web of Science ®Google Scholar
• KeerJSmeuldersMJGrayKMWilliamsHDMutants of Mycobacterium smegmatis impaired in stationary-phase survivalMicrobiology2000146Pt 9 2209 221710974108
   PubMed Web of Science ®Google Scholar
• RendinaARTaylorWSGibsonKThe design and synthesis of inhibitors of dethiobiotin synthetase as potential herbicidesPestic Sci1999553 236 247
   Google Scholar
• OkamiYKitaharaTHamadaMNaganawaHKondoSStudies on a new amino acid antibiotic, amiclenomycinJ Antibiot (Tokyo)1974279 656 6644436150
   PubMed Web of Science ®Google Scholar
• SandmarkJMannSMarquetASchneiderGStructural basis for the inhibition of the biosynthesis of biotin by the antibiotic amiclenomycinJ Biol Chem200227745 43352 4335812218056
   PubMed Web of Science ®Google Scholar
• ShiCGedersTWParkSWMechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in Mycobacterium tuberculosisJ Am Chem Soc201113345 18194 1820121988601
   PubMed Web of Science ®Google Scholar
• BermanHMThe Protein Data BankNucleic Acids Res2000281 235 24210592235
   PubMed Web of Science ®Google Scholar
• Dassault Systèmes BIOVIADiscovery Studio Modeling EnvironmentSan DiegoDassault Systèmes2015
   Google Scholar
• MurrayCWReesDCThe rise of fragment-based drug discoveryNat Chem200913 187 19221378847
   PubMed Web of Science ®Google Scholar
• PetitJMeuriceNKaiserCMaggioraGSoftening the Rule of Five – where to draw the line?Bioorg Med Chem20122018 5343 535122222160
   PubMed Web of Science ®Google Scholar
• DaiRWilsonDJGedersTWAldrichCCFinzelBCInhibition of Mycobacterium tuberculosis transaminase BioA by aryl hydrazines and hydrazidesChembiochem2014154 575 58624482078
   PubMed Web of Science ®Google Scholar
• PetheKSequeiraPCAgarwallaSA chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyNat Commun20101 5720975714
   PubMed Web of Science ®Google Scholar
• KohanskiMADwyerDJHayeteBLawrenceCACollinsJJA common mechanism of cellular death induced by bactericidal antibioticsCell20071305 797 81017803904
   PubMed Web of Science ®Google Scholar
• PalominoJCMartinACamachoMGuerraHSwingsJPortaelsFResazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosisAntimicrob Agents Chemother2002468 2720 272212121966
   PubMed Web of Science ®Google Scholar
• PalominoJCMartinAPortaelsFRapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methodsClin Microbiol Infect2007138 754 76217378933
   PubMed Web of Science ®Google Scholar